Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of a retrospective analysis of real-world data in the Journal of Comparative Effectiveness Research (JCER). The study ...

targeting calpain-2 for people living with amyotrophic lateral sclerosis (ALS). With the clinical hold lifted, Amylyx is now working to open U.S. sites for screening, enrollment, and dosing.

MAID is currently legal in 10 states and Washington, D.C., but eight other states are considering similar laws this year.

Treatment with intravenous (IV) edaravone was associated with fewer reported disease progression milestones and deaths in patients with amyotrophic ...

Neuralink’s brain-computer interface technology also has been discussed for other potential uses, for example, in mental health treatments for anxiety, depression or post-traumatic stress disorder ...

Joseph Smith, 71, and others stole more than $450,000 in disability benefits from the man between roughly 2015 and 2020, when ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Israeli journalist Moshe Nussbaum whose speech is impaired due to ALS (amyotrophic lateral sclerosis), talks in a ... President Joe Biden. In the U.S., authorities recently charged a high school ...

What started as a small birthday bash to support those with neuro-degenerative diseases has expanded to a rocking Jersey ...

according to the U.S. Attorney’s Office for the District of Massachusetts. There’s no cure for ALS, or amyotrophic lateral sclerosis, a disease that affects the nervous system and the ability ...

But universities must assume the costs of patenting and licensing the inventions, so that’s why Bayh-Dole allows them to retain royalties. Universities can re-invest the licensing revenue in new ...